Altria Q2 2022 Earnings Report
Key Takeaways
Altria Group, Inc. reported a decrease in net revenues and reported diluted EPS for Q2 2022 compared to Q2 2021. However, adjusted diluted EPS increased. The company reaffirms its guidance for 2022 full-year adjusted diluted EPS.
Smokeable products segment delivered solid operating companies income growth, driven by Marlboro's resilience.
Progress made toward Vision through investments, including supporting the expansion of on!.
FDA has the opportunity to create a mature, regulated marketplace of smoke-free products.
Reaffirmed guidance to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93.
Altria
Altria
Altria Revenue by Segment
Forward Guidance
Altria reaffirms its guidance to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93, representing a growth rate of 4% to 7% from an adjusted diluted EPS base of $4.61 in 2021.
Positive Outlook
- Planned investments in enhancement of digital consumer engagement system.
- Increased smoke-free product research, development and regulatory preparation expenses.
- Marketplace activities in support of smoke-free products.
- Accounts for a range of scenarios.
- Anticipated inflationary increases in MSA expenses and direct and indirect materials costs.
Challenges Ahead
- Conditions related to the economy, including the impact of increased inflation, rising interest rates and global supply chain disruptions.
- Impact of current and future COVID-19 variants and mitigation strategies.
- ATC dynamics, including tobacco usage occasions, available disposable income, purchasing patterns and adoption of smoke-free products.
- Regulatory and legislative developments.
- Impacts of the Russian invasion of Ukraine.
Revenue & Expenses
Visualization of income flow from segment revenue to net income